1.5 Abstract in rivista

1.5 Abstract in rivista: [4036] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 4.036

The role of descending aorta diastolic reverse flow in the quantification of aortic regurgitation by CMR

2020 La Mura, L; Teixido-Tura, G; Guala, A; Ruiz-Munoz, A; Servato, Ml; Fassano, N; Valente, F; Lopez-Sainz, A; Galian-Gay, L; Gonzalez-Alujas, T; Cinque, A; Ferreira, I; Evangelista, A; Galderisi, M; Rodriguez-Palomares, Jf

Evaluation of aortic regurgitation severity grade in bicuspid valve patients: differences between echocardiography and CMR

2020 La Mura, L; Barletta, M; Sorrentino, R; Servato, Ml; Guala, A; Teixido-Tura, G; Ruiz-Munoz, A; Evangelista, A; Rodriguez-Palomares, Jf

A RARE CASE OF CARDIAC INVOLVEMENT IN GAUCHER DISEASE

2020 La Mura, L; Renis, M; D'Amato, M; Servato, M; Fassano, N; La Mura, G

UNUSUAL CASE OF HEART FAILURE IN YOUNG WOMAN

2020 La Mura, L; Renis, M; D'Amato, M; Strada, S; Cinque, A; La Mura, G

Relationship between aortic distensibility and aortic regurgitation depending on aortic valve anatomy. A CMR study

2020 La Mura, L.; Teixido-Tura, G; Guala, A; Ruiz-Munoz, A; Servato, Ml; Fassano, N; Valente, F; Lopez-Sainz, A; Galian-Gay, L; Gonzalez-Alujas, T; Cinque, A; Ferreira, I; Evangelista, A; Galderisi, M; Rodriguez-Palomares, Jf

Relationship between aortic distensibility and aortic regurgitation assessed by CMR in bicuspid valve patients

2019 La Mura, L; Teixidó, G; Pisaniello, M; Strada, S; Ruiz-muñoz, A; Guala, A; Valente, F; Servato, Ml; Granato, C; Sainz, Al; Galian, L; Gonzalez-alujas, T; Rodriguez-palomares, Jf; Evangelista, A

335 CORONARY CT SCREENING: A PRIMARY ROLE IN CORONARY EVENTS PREVENTION

2023 Mura, Lucia La; Izzo, Carmine

627 INTRACAVITARY CORONARY ARTERIES: IS IT REALLY A RARE FINDING? A CORONARY CT STUDY

2023 La Mura, Lucia; Fassano, Nicolas Jose

Quality-of-life (QoL) in COLUMBUS part 1: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus vemurafenib (VEM) or ENCO in braf-mutant melanoma

2017 Ascierto, P

Development of muscle spasm during Vismodegib treatment and the effect of treatment interruptions: exploratory analyses from the STEVIE study

2016 Kunstfeld, R; Hauschild, A; Basset-Seguin, N; Hansson, J; Dreno, B; Mortier, L; Ascierto, P; Licitra, L; Dimier, N; Xynos, I; Grob, Jj

Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers

2017 Ascierto, P

Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad-hoc expanded access program (EAP)

2018 Ascierto, P

Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032

2018 Ascierto, P

OUTCOMES FOLLOWING CESSATION OF BRAF +/- MEK INHIBITION AFTER ACHIEVING COMPLETE RESPONSE IN BRAF MUTANT ADVANCED MELANOMA

2016 Girgis, C; Vanella, V; Menzies, Am; Guminski, A; Kefford, Rf; Long, Gv; Ascierto, P; Carlino, Ms

Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511)

2018 Ascierto, P

CD73 as biomarker of advanced melanoma response to immunotherapy

2018 Morello, S; Sorrentino, C; Frratangelo, F; Pinto, A; Capone, M; Madonna, G; Mallardo, D; Grimaldo, Ma; Giannarelli, D; Ascierto, P

Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanoma

2017 Ascierto, P

Efficacy of BMS-986016, a monoclonal antibody that targets lymphocyte activation gene-3 (LAG-3), in combination with nivolumab in pts with melanoma who progressed during prior anti-PD-1/PD-L1 therapy (mel prior IO) in all-comer and biomarker-enriched populations

2017 Ascierto, P

Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad hoc expanded access program (EAP)

2018 Ascierto, P

Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Updated results from a phase 3 trial (CheckMate 238)

2018 Ascierto, P

Titolo	Tipologia	Data di pubblicazione	Autore(i)
The role of descending aorta diastolic reverse flow in the quantification of aortic regurgitation by CMR	1.5 Abstract in rivista	2020	La Mura, L; Teixido-Tura, G; Guala, A; Ruiz-Munoz, A; Servato, Ml; Fassano, N; Valente, F; Lopez-Sainz, A; Galian-Gay, L; Gonzalez-Alujas, T; Cinque, A; Ferreira, I; Evangelista, A; Galderisi, M; Rodriguez-Palomares, Jf
Evaluation of aortic regurgitation severity grade in bicuspid valve patients: differences between echocardiography and CMR	1.5 Abstract in rivista	2020	La Mura, L; Barletta, M; Sorrentino, R; Servato, Ml; Guala, A; Teixido-Tura, G; Ruiz-Munoz, A; Evangelista, A; Rodriguez-Palomares, Jf
A RARE CASE OF CARDIAC INVOLVEMENT IN GAUCHER DISEASE	1.5 Abstract in rivista	2020	La Mura, L; Renis, M; D'Amato, M; Servato, M; Fassano, N; La Mura, G
UNUSUAL CASE OF HEART FAILURE IN YOUNG WOMAN	1.5 Abstract in rivista	2020	La Mura, L; Renis, M; D'Amato, M; Strada, S; Cinque, A; La Mura, G
Relationship between aortic distensibility and aortic regurgitation depending on aortic valve anatomy. A CMR study	1.5 Abstract in rivista	2020	La Mura, L.; Teixido-Tura, G; Guala, A; Ruiz-Munoz, A; Servato, Ml; Fassano, N; Valente, F; Lopez-Sainz, A; Galian-Gay, L; Gonzalez-Alujas, T; Cinque, A; Ferreira, I; Evangelista, A; Galderisi, M; Rodriguez-Palomares, Jf
Relationship between aortic distensibility and aortic regurgitation assessed by CMR in bicuspid valve patients	1.5 Abstract in rivista	2019	La Mura, L; Teixidó, G; Pisaniello, M; Strada, S; Ruiz-muñoz, A; Guala, A; Valente, F; Servato, Ml; Granato, C; Sainz, Al; Galian, L; Gonzalez-alujas, T; Rodriguez-palomares, Jf; Evangelista, A
335 CORONARY CT SCREENING: A PRIMARY ROLE IN CORONARY EVENTS PREVENTION	1.5 Abstract in rivista	2023	Mura, Lucia La; Izzo, Carmine
627 INTRACAVITARY CORONARY ARTERIES: IS IT REALLY A RARE FINDING? A CORONARY CT STUDY	1.5 Abstract in rivista	2023	La Mura, Lucia; Fassano, Nicolas Jose
Quality-of-life (QoL) in COLUMBUS part 1: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus vemurafenib (VEM) or ENCO in braf-mutant melanoma	1.5 Abstract in rivista	2017	Ascierto, P
Development of muscle spasm during Vismodegib treatment and the effect of treatment interruptions: exploratory analyses from the STEVIE study	1.5 Abstract in rivista	2016	Kunstfeld, R; Hauschild, A; Basset-Seguin, N; Hansson, J; Dreno, B; Mortier, L; Ascierto, P; Licitra, L; Dimier, N; Xynos, I; Grob, Jj
Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers	1.5 Abstract in rivista	2017	Ascierto, P
Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad-hoc expanded access program (EAP)	1.5 Abstract in rivista	2018	Ascierto, P
Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032	1.5 Abstract in rivista	2018	Ascierto, P
OUTCOMES FOLLOWING CESSATION OF BRAF +/- MEK INHIBITION AFTER ACHIEVING COMPLETE RESPONSE IN BRAF MUTANT ADVANCED MELANOMA	1.5 Abstract in rivista	2016	Girgis, C; Vanella, V; Menzies, Am; Guminski, A; Kefford, Rf; Long, Gv; Ascierto, P; Carlino, Ms
Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511)	1.5 Abstract in rivista	2018	Ascierto, P
CD73 as biomarker of advanced melanoma response to immunotherapy	1.5 Abstract in rivista	2018	Morello, S; Sorrentino, C; Frratangelo, F; Pinto, A; Capone, M; Madonna, G; Mallardo, D; Grimaldo, Ma; Giannarelli, D; Ascierto, P
Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanoma	1.5 Abstract in rivista	2017	Ascierto, P
Efficacy of BMS-986016, a monoclonal antibody that targets lymphocyte activation gene-3 (LAG-3), in combination with nivolumab in pts with melanoma who progressed during prior anti-PD-1/PD-L1 therapy (mel prior IO) in all-comer and biomarker-enriched populations	1.5 Abstract in rivista	2017	Ascierto, P
Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad hoc expanded access program (EAP)	1.5 Abstract in rivista	2018	Ascierto, P
Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Updated results from a phase 3 trial (CheckMate 238)	1.5 Abstract in rivista	2018	Ascierto, P

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 4.036

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext3694
open181
reserved122
restricted39